Miriam Longo

The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs

Dario Giugliano, Miriam Longo, Simona Signoriello et al. · Cardiovascular Diabetology · 2022 · 147 citations · Full text

Pharmacy, Cardiology, Pharmacology +17

Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial

Dario Giugliano, Miriam Longo, Paola Caruso et al. · Diabetes Care · 2021 · 65 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Antibiotic resistance in diabetic foot infection: how it changed with COVID-19 pandemic in a tertiary care center

Paola Caruso, Maria Ida Maiorino, Margherita Macera et al. · Diabetes Research and Clinical Practice · 2021 · 55 citations · Full text

Health Professions, Infectious Diseases, Podiatric Medicine +17

Liraglutide for Lower Limb Perfusion in People With Type 2 Diabetes and Peripheral Artery Disease

Paola Caruso, Maria Ida Maiorino, Miriam Longo et al. · JAMA Network Open · 2024 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak?

Paola Caruso, Miriam Longo, Katherine Esposito et al. · Diabetes Research and Clinical Practice · 2020 · 52 citations · Full text

Veterinary Medicine, Infectious Diseases, Virology +16